These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 16901407)

  • 1. Lipoprotein-associated phospholipase A2: pathogenic mechanisms and clinical utility for predicting cardiovascular events.
    Nambi V; Ballantyne CM
    Curr Atheroscler Rep; 2006 Sep; 8(5):374-81. PubMed ID: 16901407
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipoprotein-associated phospholipase A2 (platelet-activating factor acetylhydrolase) and cardiovascular disease.
    Caslake MJ; Packard CJ
    Curr Opin Lipidol; 2003 Aug; 14(4):347-52. PubMed ID: 12865731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship of lipoprotein-associated phospholipase A₂ mass and activity with incident vascular events among primary prevention patients allocated to placebo or to statin therapy: an analysis from the JUPITER trial.
    Ridker PM; MacFadyen JG; Wolfert RL; Koenig W
    Clin Chem; 2012 May; 58(5):877-86. PubMed ID: 22419750
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipoprotein-associated phospholipase A2: a novel marker of cardiovascular risk and potential therapeutic target.
    Macphee C; Benson GM; Shi Y; Zalewski A
    Expert Opin Investig Drugs; 2005 Jun; 14(6):671-9. PubMed ID: 16004595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Review of the evidence for the clinical utility of lipoprotein-associated phospholipase A2 as a cardiovascular risk marker.
    Corson MA; Jones PH; Davidson MH
    Am J Cardiol; 2008 Jun; 101(12A):41F-50F. PubMed ID: 18549871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipoprotein-associated phospholipase A2 as a biomarker for coronary disease and stroke.
    Caslake MJ; Packard CJ
    Nat Clin Pract Cardiovasc Med; 2005 Oct; 2(10):529-35. PubMed ID: 16186851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of lipoprotein-associated phospholipase A2 (Lp-PLA₂) in cardiovascular disease.
    Ikonomidis I; Michalakeas CA; Lekakis J; Parissis J; Anastasiou-Nana M
    Rev Recent Clin Trials; 2011 May; 6(2):108-13. PubMed ID: 21241231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of darapladib on plasma lipoprotein-associated phospholipase A2 activity and cardiovascular biomarkers in patients with stable coronary heart disease or coronary heart disease risk equivalent: the results of a multicenter, randomized, double-blind, placebo-controlled study.
    Mohler ER; Ballantyne CM; Davidson MH; Hanefeld M; Ruilope LM; Johnson JL; Zalewski A;
    J Am Coll Cardiol; 2008 Apr; 51(17):1632-41. PubMed ID: 18436114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipoprotein-associated phospholipase A(2): a promising vascular-specific marker for screening cardiovascular risk?
    Lee JH; Engler MM
    Prog Cardiovasc Nurs; 2009 Dec; 24(4):181-9. PubMed ID: 20002343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipoprotein-associated phospholipase A2 predicts future cardiovascular events in patients with coronary heart disease independently of traditional risk factors, markers of inflammation, renal function, and hemodynamic stress.
    Koenig W; Twardella D; Brenner H; Rothenbacher D
    Arterioscler Thromb Vasc Biol; 2006 Jul; 26(7):1586-93. PubMed ID: 16627803
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipoprotein-associated phospholipase A2 as a novel risk marker for cardiovascular disease: a systematic review of the literature.
    Madjid M; Ali M; Willerson JT
    Tex Heart Inst J; 2010; 37(1):25-39. PubMed ID: 20200624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical review: Lipoprotein-associated phospholipase A2, a novel inflammatory biomarker and independent risk predictor for cardiovascular disease.
    Sudhir K
    J Clin Endocrinol Metab; 2005 May; 90(5):3100-5. PubMed ID: 15713711
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A prospective evaluation of lipoprotein-associated phospholipase A(2) levels and the risk of future cardiovascular events in women.
    Blake GJ; Dada N; Fox JC; Manson JE; Ridker PM
    J Am Coll Cardiol; 2001 Nov; 38(5):1302-6. PubMed ID: 11691499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipoprotein-associated phospholipase A2: a cardiovascular risk predictor and a potential therapeutic target.
    Ali M; Madjid M
    Future Cardiol; 2009 Mar; 5(2):159-73. PubMed ID: 19371190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lp-PLA2: A new target for statin therapy.
    Braun LT; Davidson MH
    Curr Atheroscler Rep; 2010 Jan; 12(1):29-33. PubMed ID: 20425268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of low-density lipoprotein apheresis on lipoprotein-associated phospholipase A2.
    Moriarty PM; Gibson CA
    Am J Cardiol; 2005 May; 95(10):1246-7. PubMed ID: 15878003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipoprotein-associated phospholipase A2 and its association with cardiovascular outcomes in patients with acute coronary syndromes in the PROVE IT-TIMI 22 (PRavastatin Or atorVastatin Evaluation and Infection Therapy-Thrombolysis In Myocardial Infarction) trial.
    O'Donoghue M; Morrow DA; Sabatine MS; Murphy SA; McCabe CH; Cannon CP; Braunwald E
    Circulation; 2006 Apr; 113(14):1745-52. PubMed ID: 16537575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipoprotein-associated phospholipase A2: review and recommendation of a clinical cut point for adults.
    Lanman RB; Wolfert RL; Fleming JK; Jaffe AS; Roberts WL; Warnick GR; McConnell JP
    Prev Cardiol; 2006; 9(3):138-43. PubMed ID: 16849876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Markers of inflammation and their clinical significance.
    Ballantyne CM; Nambi V
    Atheroscler Suppl; 2005 May; 6(2):21-9. PubMed ID: 15823493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of lipoprotein-associated phospholipase A2 as a marker for atherosclerosis.
    Virani SS; Nambi V
    Curr Atheroscler Rep; 2007 Aug; 9(2):97-103. PubMed ID: 17877917
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.